Purpose Cardiac autonomic dysfunction is one of the main pillars of cardiovascular
pathophysiology. The purpose of this review is to provide an overview of the current state of …

Survivors of myocardial infarction are at risk of life-threatening ventricular tachycardias (VTs)
later in their lives. Current guidelines for implantable cardioverter defibrillators (ICDs) …

Objective. Ageing is one of the risk factors associated with cardiovascular diseases
including cardiac arrhythmias and heart failure. Ageing‐related cardiac dysfunction involves …

Abstract Approximately 30% to 70% of patients with cirrhosis have QT interval prolongation.
In patients without cirrhosis, QT prolongation is associated with an increased risk of …

Abnormality in myocardial copper homeostasis is believed to contribute to the development
of cardiomyopathy. Trientine, a copper-chelating drug used in the management of patients …

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are gaining ground as standard therapy
for heart failure with a class-I recommendation in the recently updated heart failure …

This review is focusing on the understanding of various factors and components governing
and controlling the occurrence of ventricular arrhythmias including (i) the role of various ion …

Regulation of cell-to-cell communication in the heart by the gap junction protein Connexin43
(Cx43) involves modulation of Cx43 phosphorylation state by protein kinases, and …

Background Heart failure (HF) is a severe complication of acute ST-segment elevation
myocardial infarction (STEMI). Its incidence is associated with myocardial infarction location …

Angiotensin receptor–neprilysin inhibitor (ARNI) use has become increasingly popular.
Current guidelines recommend using ARNI therapy for heart failure with reduced (HFrEF) …